Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial

[1]  C. la Vecchia,et al.  Global trends and predictions in ovarian cancer mortality. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  C. Laskin,et al.  Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study , 2016, PloS one.

[3]  S. Richard,et al.  Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation? , 2016, Journal of minimally invasive gynecology.

[4]  T. Lawrie,et al.  Techniques for the interruption of tubal patency for female sterilisation. , 2016, The Cochrane database of systematic reviews.

[5]  T. Raine-Bennett,et al.  Experience With Opportunistic Salpingectomy in a Large, Community-Based Health System in the United States , 2016, Obstetrics and gynecology.

[6]  R. Kučera,et al.  Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion , 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  S. Shim,et al.  Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis. , 2016, European journal of cancer.

[8]  M. Mogos,et al.  National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011. , 2015, American journal of obstetrics and gynecology.

[9]  J. McAlpine,et al.  Opportunistic salpingectomy for ovarian cancer prevention , 2015, Gynecologic Oncology Research and Practice.

[10]  V. Bini,et al.  Anti-mullerian hormone concentration during the third trimester of pregnancy and puerperium: a longitudinal case–control study in normal and diabetic pregnancy , 2015, Endocrine.

[11]  R. Kimmig,et al.  Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay , 2015, Reproductive Biology and Endocrinology.

[12]  M. Eijkemans,et al.  Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study. , 2015, Human reproduction.

[13]  S. Mirkin,et al.  The utility of measuring anti-Müllerian hormone in predicting menopause , 2015, Climacteric : the journal of the International Menopause Society.

[14]  J. García-Donas,et al.  Surgical outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women. , 2015, Journal of minimally invasive gynecology.

[15]  H. Grönberg,et al.  Ovarian cancer risk after salpingectomy: a nationwide population-based study. , 2015, Journal of the National Cancer Institute.

[16]  D. Huntsman,et al.  Costs and Benefits of Opportunistic Salpingectomy as an Ovarian Cancer Prevention Strategy , 2015, Obstetrics and gynecology.

[17]  S. Kjær,et al.  Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case–control study , 2015, Acta obstetricia et gynecologica Scandinavica.

[18]  F. Broekmans,et al.  Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. , 2014, Human reproduction update.

[19]  Richard A. Anderson,et al.  The physiology and clinical utility of anti-Mullerian hormone in women. , 2014, Human reproduction update.

[20]  D. Huntsman,et al.  Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. , 2014, American journal of obstetrics and gynecology.

[21]  M. Gajda,et al.  Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate , 2014, Journal of Cancer Research and Clinical Oncology.

[22]  G. Mitchell,et al.  Prophylactic Bilateral Salpingectomy as a Prevention Strategy in Women at High-Risk of Ovarian Cancer: A Mini-Review , 2014, Front. Oncol..

[23]  E. Carey,et al.  Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. , 2013, Fertility and sterility.

[24]  F. Zullo,et al.  Prophylactic Salpingectomy in Premenopausal Low-Risk Women for Ovarian Cancer: Primum Non Nocere , 2013 .

[25]  R. Kimmig,et al.  Anti-Mullerian-hormone levels during pregnancy and postpartum , 2013, Reproductive Biology and Endocrinology.

[26]  P. Vercellini,et al.  Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. , 2012, Fertility and sterility.

[27]  J. Wischhusen,et al.  The post-reproductive Fallopian tube: better removed? , 2011, Human reproduction.

[28]  M. Solaymani-Dodaran,et al.  Predicting age at menopause from serum antimüllerian hormone concentration , 2011, Menopause.

[29]  L. Brinton,et al.  Serum antimüllerian hormone in healthy premenopausal women. , 2011, Fertility and sterility.

[30]  D. Oram,et al.  Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status , 2011, BJOG : an international journal of obstetrics and gynaecology.

[31]  A. Berchuck,et al.  Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. , 2010, Obstetrics and Gynecology.

[32]  F. Stewart,et al.  Longitudinal assessment of antimüllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. , 2010, Fertility and sterility.

[33]  M. Solaymani-Dodaran,et al.  A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause , 2009, Menopause.

[34]  F. Ghezzi,et al.  Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? , 2009, BJOG : an international journal of obstetrics and gynaecology.

[35]  M. Sezik,et al.  Total salpingectomy during abdominal hysterectomy: Effects on ovarian reserve and ovarian stromal blood flow , 2007, The journal of obstetrics and gynaecology research.

[36]  G. Cevenini,et al.  3 to 5 Years Later: Long-term Effects of Prophylactic Bilateral Salpingectomy on Ovarian Function. , 2017, Journal of minimally invasive gynecology.

[37]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[38]  M. Boulvain,et al.  Techniques for the interruption of tubal patency for female sterilisation. , 2003, The Cochrane database of systematic reviews.

[39]  N. Dubrawsky.  Cancer statistics , 2022 .